Boehringer Ingelheim announced this week its intent to join The Leukemia and Lymphoma Society's (LLS) Beat AML initiative, which aims to advance treatments for patients with acute myeloid leukemia (AML).
Adore Me, an e-commerce startup, recently partnered with PinkChoseMe Foundation, a nonprofit organization focused on teaching women about preventative care for breast cancer, during Breast Cancer Awareness Month.
Johnson & Johnson Innovation LLC (JJI) announced this week that it has created the Center for Device Innovation at Texas Medical Center as a collaboration between JJI and TMC to accelerate the development of medical devices.
President Barack Obama recently signed into law the Military Construction, Veterans Affairs, and Related Agencies Appropriation Bill, which removes barriers to employment for Licensed Marriage and Family Therapists (LMFTs) to work for the U.S. Department of Veterans Affairs (VA).
The Leukemia and Lymphoma Society (LLS) recently launched a collaborative clinical trial for acute myeloid leukemia (AML), a deadly disease for which treatments have not improved much in the last four decades.
During a major symposium hosted by the Cure Alzheimer's Fund at the Boston Public Library on Wednesday, Oct. 19, three leading Alzheimer’s researchers discussed recent findings for how to slow and prevent the disease.
Researchers unveiled new information this week in the American Heart Association’s journal 'Circulation,' showing that people with pacemakers or defibrillators who experience short episodes of atrial fibrillation have a very low risk of stroke.
The National Institutes of Health (NIH) announced this week that, with the support of a grant from the Bill & Melinda Gates Foundation, it is funding a $30.5 million multi-country trial aimed at preventing and managing lung diseases.
Amgen has announced a phase-three study analyzing how XGEVA competes with zoledronic acid when it comes to meeting the primary endpoint of non-inferiority in delaying the time to first on-study skeletal-related event (SRE) in patients with multiple myeloma.
A recent study published in the 'New England Journal of Medicine' examined how mammography screenings have affected reported breast cancer incidence, tumor size at diagnosis, related mortality and potential for over-diagnosis.